ArticleBMC infectious diseases2025
Deep cutaneous fungal infection in an immunocompetent individual caused by a biological pesticide: a rare case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cutaneous and Subcutaneous Hyalohyphomycosis Caused by Purpureocillium Lilacinum in a Tertiary Referral Hospital in Central China.The Journal of dermatology · 2026Article
- Chronic Elbow Nodules Caused by Fomitiporella Fungus in Immunocompetent Patients, United States.Emerging infectious diseases · 2026Article
- Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States.Emerging infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPurpureocillium lilacinum is a type of fungus that is found all over the world and is known for its ability to help control pests, especially those that harm plants. Generally, this fungus does not cause serious problems for healthy people, but it can lead to severe infections in individuals with weakened immune systems. In this report, we discuss a rare case where a healthy person developed an infection after being exposed to a biopesticide containing this fungus. CASE PRESENTATION: A 66-year-old woman presented with recurrent erythematous lesions on her face and arms that had chronically recurred over a 10-year period. Based on the patient's clinical symptoms, fungal culture results, and a thorough review of the medical history, a diagnosis of potential infection with Purpureocillium lilacinum is suggested. This patient was treated for three months with oral itraconazole (400 mg), which led to the complete healing of her skin lesions without any recurrence. DISCUSSION AND
conclusionThis is the first known case of a deep fungal infection linked to work with biopesticides. Our findings highlight the potential risks of using these products and emphasize the need for proper safety precautions and ongoing monitoring of fungal infections in various groups of people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.